Eli Lilly Launches Foundayo With $1.5 Billion Pre-Stocked Inventory
Eli Lilly formally launched Foundayo (orforglipron) eight days after FDA approval, having pre-stocked $1.5 billion worth of the drug. The oral obesity market now features a direct Lilly vs Novo Nordisk competition.